NanoRepro AG (ETR:NN6)
Germany · Delayed Price · Currency is EUR 1.655
-0.065 (-3.78%)
Sep 25, 2026, 1:17 PM CET
NanoRepro AG Market Cap
NanoRepro AG has a market cap or net worth of €21.69 million as of September 24, 2026.
Market Cap
21.69M
Enterprise Value
13.93M
Revenue
4.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.66
ChartMarket Cap Chart
Since October 10, 2008, NanoRepro AG's market cap has increased from 12.43M to 21.69M, an increase of 74.58%. That is a compound annual growth rate of 3.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 21.69M | 14.29% |
| Dec 30, 2025 | 18.98M | 7.89% |
| Dec 30, 2024 | 17.60M | -31.51% |
| Dec 29, 2023 | 25.69M | -9.71% |
| Dec 30, 2022 | 28.45M | -70.56% |
| Dec 30, 2021 | 96.65M | 175.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 57.80B |
| Bayer Aktiengesellschaft | 48.68B |
| Siemens Healthineers AG | 41.41B |
| Fresenius SE & Co. KGaA | 25.97B |
| FamiCord AG | 51.25M |
| Pentixapharm Holding AG | 46.47M |
| MeVis Medical Solutions AG | 41.86M |
| Maternus-Kliniken Aktiengesellschaft | 29.36M |